MS

Madhavi Sachin Mulay

Active Director Director DIN 11125440
DIN 11125440 First appointment May 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Madhavi Sachin Mulay

Data last updated:

Madhavi Sachin Mulay is a Director at Abhinavayan Biotech Private Limited (since 2025). The company operates in Biotechnology.

DIN 11125440
Primary Designation Director
Industry Biotechnology
First Appointment 26 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Abhinavayan Biotech Private Limited U72100MH2025PTC449231
Director26 May 20252025Active

Board colleagues of Madhavi Sachin Mulay

Directorship timeline

Open interactive timeline →
Abhinavayan Biotech Private Limited
Premium access

Shareholding and investment profile for Madhavi Sachin Mulay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhavi Sachin Mulay

Madhavi Sachin Mulay currently holds 1 directorship: Abhinavayan Biotech Private Limited (Director, since 26 May 2025).

Madhavi Sachin Mulay was first appointed on 26 May 2025 as Director at Abhinavayan Biotech Private Limited.

The current boards of Madhavi Sachin Mulay's companies include Megha Goyal (Abhinavayan Biotech Private Limited), Nagaraj Gowda (Abhinavayan Biotech Private Limited), Nagaraj Gowda Ranjita (Abhinavayan Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available